Jan 30, 2016

Study findings confirm sugar’s role in cancer survival; could help in design of clinical trials to test PI3K inhibitors

Posted by in category: biotech/medical

PI3K (phosphoinositide 3-kinase) is a cell-signaling molecule found tied to breast, ovarian, and endometrial cancers.

Important insights into the biology that underlies glycolysis, the metabolic process that enables cancer cells to generate biomass and energy, have been revealed by new research, confirming the importance of sugar to cancer survival.

Read more

Comments are closed.